Expert review of respiratory medicine最新文献_第9页

High burden of severe and very severe undernutrition among adults with tuberculosis: findings from a state wide operational research in Chhattisgarh, India. 成人结核病患者严重和极严重营养不良的高负担：来自印度恰蒂斯加尔邦一项全国性业务研究的结果。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-04-01 Epub Date: 2025-10-05 DOI: 10.1080/17476348.2025.2569845

Vishnu Gupta, Chetanya Malik, Kalpita Shringarpure, Himanshu A Gupte, Hemant D Shewade, Khemraj Sonwani, Vikash Ranjan Keshri

{"title":"High burden of severe and very severe undernutrition among adults with tuberculosis: findings from a state wide operational research in Chhattisgarh, India.","authors":"Vishnu Gupta, Chetanya Malik, Kalpita Shringarpure, Himanshu A Gupte, Hemant D Shewade, Khemraj Sonwani, Vikash Ranjan Keshri","doi":"10.1080/17476348.2025.2569845","DOIUrl":"10.1080/17476348.2025.2569845","url":null,"abstract":"Background: Undernutrition drives the TB epidemic in India with 4-5 times higher mortality among adults with severe/very severe undernutrition. We assessed proportion of severe/very severe undernutrition among adults with TB and timeliness in receiving monetary support for nutrition (Direct benefit transfer-DBT) and food baskets.Research design and methods: This analytical cross-sectional study conducted in Chhattisgarh, tribal Indian state, utilized program data of adults with TB notified in public facilities under the National TB Elimination Program from April-June 2024. Body Mass Index (BMI) was categorized for nutritional status and equity in distribution of DBT and foodbaskets was evaluated using frequency, proportions, and Chi-square for trend.Results: Of 6568 adults with TB, BMI was calculated for 6397 (97%). Proportion of severe and very severe undernutrition was 22% and 13% respectively. First DBT instalment was received by 81%, with 29% receiving it within two months; 21% received foodbaskets, with similar coverage across all undernutrition categories (p > 0.05), reflecting inequity.Conclusions: There is a high burden of severe/very severe undernutrition among TB patients. Similar DBT and food basket coverage among those with severe/very severe undernutrition and other TB patients indicates inequity in distribution. Undernutrition-basedindicators and linkage of DBT and food baskets should be prioritized.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"467-473"},"PeriodicalIF":2.7,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Multimorbidity in the modulator era: challenges of managing an ageing cystic fibrosis population. 调节剂时代的多病：管理老龄化囊性纤维化人群的挑战。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-10-05 DOI: 10.1080/17476348.2025.2568244

Alex Chan, Freddy Frost, Dilip Nazareth

{"title":"Multimorbidity in the modulator era: challenges of managing an ageing cystic fibrosis population.","authors":"Alex Chan, Freddy Frost, Dilip Nazareth","doi":"10.1080/17476348.2025.2568244","DOIUrl":"10.1080/17476348.2025.2568244","url":null,"abstract":"Introduction: Cystic Fibrosis (CF) is an autosomal recessive disorder caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, leading to defective chloride ion transport and multisystem disease. The introduction of CFTR modulators, particularly elexacaftor/tezacaftor/ivacaftor (ETI), has significantly improved life expectancy and quality of life for people with CF (pwCF). As survival increases, an aging CF population faces different new challenges.Areas covered: This review aims to highlight emerging challenges and comorbidities in an aging CF population to ensure sustained benefits from recent therapeutic advancements. The review includes the discussion of the changes in lung function, nutrition, cardiometabolic diseases, malignancy risk and psychosocial health. A structured literature search was conducted using PubMed, focusing on articles published between 2000 and 2025, including recent clinical trials and international guidelines. National registry data has also been reviewed.Expert opinion: With CFTR modulators progress rapidly, the future focus should shift to refining and optimizing CF care. Standard practice should involve a multidisciplinary, proactive and preventative strategy to manage co-morbidities, ensuring the ultimate goal moving from simply extending pwCF's life to ensuring a high quality of life throughout their lifespan.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"267-277"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Insights into sinonasal disease in patients with primary ciliary dyskinesia. 原发性纤毛运动障碍患者鼻窦疾病的认识。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-10-20 DOI: 10.1080/17476348.2025.2577483

Ela Erdem Eralp, Bulent Karadag

{"title":"Insights into sinonasal disease in patients with primary ciliary dyskinesia.","authors":"Ela Erdem Eralp, Bulent Karadag","doi":"10.1080/17476348.2025.2577483","DOIUrl":"10.1080/17476348.2025.2577483","url":null,"abstract":"Introduction: Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterized by impaired motile ciliary function, resulting in defective mucociliary clearance and chronic sinopulmonary disease. Although lower airway manifestations are well known, sinonasal disease is often underrecognized or undertreated outside specialist centers, particularly in adults and in settings without routine Ear-Nose-Throat evaluation.Areas covered: Despite its clinical burden, standardized diagnostic and therapeutic protocols for sinonasal disease in PCD are limited. This review synthesizes current knowledge on the pathophysiology, clinical presentation, diagnostic approaches, and management strategies for sinonasal involvement in PCD based on recent publications. Additionally, the review highlights the burden of disease and its impact on quality of life, role of genotype-phenotype correlations, and the emerging need for disease-specific outcome measures.Expert opinion: Despite growing evidence, diagnosis and management remain inconsistent due to a lack of standardized tools and guidelines. Multidisciplinary care and implementation of validated outcome measures are essential to optimize clinical follow-up and improve quality of life in this population. Future advances in imaging, microbiome profiling, and personalized interventions are needed. Furthermore, defining a standardized criteria for sinonasal exacerbations and integrating upper airway outcomes into clinical studies will be critical for advancing both research and patient care.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"287-294"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

COPD and the burden of multimorbidity: navigating the complexity. 慢性阻塞性肺病和多重疾病的负担：在复杂性中导航。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-10-07 DOI: 10.1080/17476348.2025.2569126

Maria Kallieri, Georgios Hillas, Konstantinos Bartziokas, Stelios Loukides, Dimitrios Toumpanakis

{"title":"COPD and the burden of multimorbidity: navigating the complexity.","authors":"Maria Kallieri, Georgios Hillas, Konstantinos Bartziokas, Stelios Loukides, Dimitrios Toumpanakis","doi":"10.1080/17476348.2025.2569126","DOIUrl":"10.1080/17476348.2025.2569126","url":null,"abstract":"Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic condition that affects millions of people worldwide. The majority of patients with COPD have multiple coexisting chronic diseases, such as cardiovascular diseases, osteoporosis, lung cancer, and metabolic syndrome, a phenomenon that is known as multimorbidity. The coexistence of these diseases with COPD complicates diagnosis, treatment, and prognosis.Areas covered: This review explores the underlining mechanisms that connect COPD and multimorbidity, such as shared risk factors and pathophysiological pathways. It also highlights the challenges in managing multimorbid patients and emphasizes the fact that the complexity of comorbidities may require a multidisciplinary approach in COPD management.Expert opinion: Managing COPD in the context of multimorbidity requires a multidisciplinary approach. This approach should combine pharmacological and non-pharmacological treatments for COPD, adhere to evidence-based guidelines for managing comorbidities, and target modifiable shared risk factors to improve overall patient outcomes.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"251-266"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rituximab treatment for connective tissue diseases associated-pulmonary hypertension: a systematic literature review. 利妥昔单抗治疗结缔组织病相关肺动脉高压：系统文献综述

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-09-17 DOI: 10.1080/17476348.2025.2557634

Amany Touil, Selma Bouden, Sarra Maazaoui, Leila Rouached, Aicha Ben Tekaya, Siwar Ben Dhia, Ines Mahmoud, Rawdha Tekaya, Olfa Saidane, Leila Abdemloula

{"title":"Rituximab treatment for connective tissue diseases associated-pulmonary hypertension: a systematic literature review.","authors":"Amany Touil, Selma Bouden, Sarra Maazaoui, Leila Rouached, Aicha Ben Tekaya, Siwar Ben Dhia, Ines Mahmoud, Rawdha Tekaya, Olfa Saidane, Leila Abdemloula","doi":"10.1080/17476348.2025.2557634","DOIUrl":"10.1080/17476348.2025.2557634","url":null,"abstract":"Introduction: To evaluate the efficacy and safety of Rituximab (RTX) in the treatment of pulmonary hypertension (PH) in patients with connective tissue diseases (CTDs).Methods: A systematic review of the published literature was performed according to the PRISMA guidelines. Eligible articles were clinical trials, cohort studies, case series, and case reports of adult patients with CTD-PH treated with RTX. The selected languages were English and French.Results: Six studies fulfilled the selection criteria and two of them were prospective. Most patients were from the U.S.A. and Russia. The predominant sex was female (85.9%), and the age of the included patients ranged from 29 years to 67 years. PH was confirmed by right heart catheterization in 3 studies. The CTDs associated with PH were systemic sclerosis (3 cases), adult-onset Still's disease (one case), systemic lupus erythematosus (one case) and mixed connective tissue disease (one case). The mean number of infusions was 4.2. The mean follow-up period across all studies was 18.3 months. Clinical and paraclinical parameters before and after RTX infusions were evaluated and showed improvement. RTX for the treatment of CTD-PH appeared to be well tolerated.Conclusions: RTX seemed to be effective and safe in the treatment of CTD-PH.Systematic review registration: PROSPERO, ID: CRD420251037839.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"321-328"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical perspective on non-sleepy obstructive sleep apnea; to treat or not to treat? 非困倦性阻塞性睡眠呼吸暂停的临床观察治疗还是不治疗？

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-07-25 DOI: 10.1080/17476348.2025.2539542

Steven Luu, Budhima Nanayakkara, Brendon J Yee

{"title":"Clinical perspective on non-sleepy obstructive sleep apnea; to treat or not to treat?","authors":"Steven Luu, Budhima Nanayakkara, Brendon J Yee","doi":"10.1080/17476348.2025.2539542","DOIUrl":"10.1080/17476348.2025.2539542","url":null,"abstract":"Introduction: Excessive daytime sleepiness has traditionally been regarded as the hallmark symptom of obstructive sleep apnea (OSA), yet nearly half of individuals with OSA do not report significant sleepiness. While treatments are well established for sleepy patients, their role in non-sleepy individuals remains relatively underexplored.Areas covered: This review discusses the limitations of current tools used to measure sleepiness, evaluates the evidence for various treatment options for OSA in non-sleepy populations, and outlines key considerations for shared decision-making. We examine noninvasive therapies including positive airway pressure (PAP), oral appliance therapy, and weight loss interventions only.Expert opinion: Randomized controlled trials have not demonstrated cardiometabolic benefits of PAP therapy in non-sleepy individuals with OSA, though these studies are limited by poor PAP adherence and imprecise tools for identifying high-risk patients. As such, a pragmatic trial of PAP may be a reasonable strategy in non-sleepy people with moderate-to-severe OSA, cardiovascular comorbidities, or other OSA-related complications; provided patients are counseled about the challenges of adherence and the uncertain benefits in this population. Looking ahead, management of non-sleepy OSA will likely be guided by individualized, risk-based approaches incorporating physiological endotyping, objective biomarkers of cardiovascular risk, and patient preferences.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"227-239"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144700744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Spatially resolved airway niches: mapping epithelial-immune microenvironments in asthma. 空间解决气道壁龛：绘制哮喘的上皮免疫微环境。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-10-29 DOI: 10.1080/17476348.2025.2582244

Molham Sakkal, Anan S Jarab, Ahmad Z Al Meslamani

{"title":"Spatially resolved airway niches: mapping epithelial-immune microenvironments in asthma.","authors":"Molham Sakkal, Anan S Jarab, Ahmad Z Al Meslamani","doi":"10.1080/17476348.2025.2582244","DOIUrl":"10.1080/17476348.2025.2582244","url":null,"abstract":"Introduction: Spatially resolved omics has reconceptualized the bronchial wall as a mosaic of epithelial - immune microenvironments whose local molecular circuits drive asthma heterogeneity and medication responsiveness.Areas covered: We searched PubMed, Embase, Web of Science, and Scopus (January 2005 - July 2025) using platform-specific and disease-related keywords and identified studies that employed spatial transcriptomics, multiplex-imaging proteomics, or spatial metabolomics on human airway biopsies, ex vivo lung slices, and murine asthma models. We synthesize niches revealed by Visium-HD, Xenium, CosMx SMI, MERFISH, Imaging Mass Cytometry, MIBI, and high-resolution MALDI-MSI - IL-13-rich goblet-cell hubs, mast-cell - smooth-muscle loops, IL-17-driven neutrophil pockets, and fibroblast-remodeling zones. These investigations expose chemokine, alarmin, and lipid gradients that delineate disease-defining niches overlooked by dissociation-based assays, thereby uncovering therapeutic targets.Expert opinion: Spatial omics links molecular programmes to micro-anatomy with near-single-cell accuracy and is poised for integration into precision-medicine pipelines. Cost-effective, high-throughput 'spatial biopsies,' combined with graph-based artificial intelligence, are expected to stratify patients for biologic therapies within five years. Nonetheless, broad clinical adoption will require reduced assay costs, mitigation of RNA diffusion, harmonized FFPE workflows, and multi-omic integration across global cohorts to produce reproducible, clinically actionable airway atlases capable of personalizing prevention and treatment.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"307-320"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145380424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impairment of neural mechanosensitivity in the Long COVID haulers. COVID - 19长途运输车辆神经力学敏感性损伤。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-10-02 DOI: 10.1080/17476348.2025.2568243

Andrés Calvache-Mateo, Alberto Rodríguez-López, Alba Navas-Otero, Javier Martín Núñez, Alejandro Heredia-Ciuró, Laura López-López, Marie Carmen Valenza

{"title":"Impairment of neural mechanosensitivity in the Long COVID haulers.","authors":"Andrés Calvache-Mateo, Alberto Rodríguez-López, Alba Navas-Otero, Javier Martín Núñez, Alejandro Heredia-Ciuró, Laura López-López, Marie Carmen Valenza","doi":"10.1080/17476348.2025.2568243","DOIUrl":"10.1080/17476348.2025.2568243","url":null,"abstract":"Background: The aim of this study was to evaluate and characterize the alteration in mechanosensitivity in Long COVID haulers as well as its impact on patients' functionality and quality of life.Research design and methods: In this study there were two groups: a group of Long COVID haulers and a group of healthy controls matched for age and sex. The mechanosensitivity clinical profile and peripheral nerve mechanosensitivity were evaluated. The mechanosensitivity clinical profile included the functionality and quality of life (World Health Organization Disability Assessment Schedule 2.0, Patient-Reported Outcomes Measurement Information System, EuroQol-5 Dimensions) and neural mechanosensitivity (Leeds Assessment of Neuropathic Symptoms and Signs). The peripheral nerve mechanosensitivity included neurodynamic tests (median, radial, ulnar, slump test and straight leg raise).Results: A total of 64 patients were included in the study (Long COVID haulers group n = 33, healthy controls group n = 31). Long COVID haulers group obtained significantly worse results in functionality (p < 0.001), quality of life (p < 0.001), neural mechanosensitivity (p < 0.001) and peripheral nerve mechanosensitivity (p < 0.001).Conclusions: Long COVID haulers have significant alterations in neural mechanosensitivity, contributing to a greater degree of functional impairment and poorer quality of life.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"329-335"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145180800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Do we know about respiratory syncytial virus in Türkiye? 我们知道呼吸道合胞病毒在<s:1>基耶病毒？

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-10-04 DOI: 10.1080/17476348.2025.2569125

Dilşah Başkol Elik, Gökhan Vatansever, Selin Ece Taşbakan, Serdal Ateş, Hüsnü Pullukçu, Meltem Taşbakan, İftihar Köksal

{"title":"Do we know about respiratory syncytial virus in Türkiye?","authors":"Dilşah Başkol Elik, Gökhan Vatansever, Selin Ece Taşbakan, Serdal Ateş, Hüsnü Pullukçu, Meltem Taşbakan, İftihar Köksal","doi":"10.1080/17476348.2025.2569125","DOIUrl":"10.1080/17476348.2025.2569125","url":null,"abstract":"Background: Respiratory Syncytial Virus (RSV) is a major cause of severe respiratory illness in infants, older adults, and immunocompromised individuals. However, data on physicians' knowledge and attitudes toward RSV and its prevention in Türkiye are limited. The aim of this study was to evaluate the knowledge and attitudes of physicians in Türkiye about RSV.Research design and methods: A cross-sectional online survey was conducted among physicians in Türkiye between October and November 2024.Results: A total of 1270 physicians (median age: 35; 62.44% female) participated, 30.5% of whom specialized in Infectious Diseases (ID). While 43.54% correctly identified RSV symptoms, only 15.9% recognized high-risk groups, and 49.7% were familiar with associated clinical conditions. ID specialists had significantly greater knowledge of symptoms (p = 0.015) and complications (p < 0.001) compared to other physicians. Overall, 51.57% perceived the national RSV burden as high. However, only 40.31% were aware of prevention tools. Although 51.88% knew about FDA-approved RSV vaccines, just 21.54% knew they were not yet available in Türkiye. Among vaccine-aware participants, most would recommend it to elderly (85.28%), while fewer supported maternal vaccination (58.87%).Conclusions: These findings reveal that despite higher knowledge among ID physicians, overall awareness of RSV and its prevention is inadequate.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"337-344"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An update on the role of ultrasound lung artifacts in the diagnosis of respiratory diseases. 超声肺伪影在呼吸系统疾病诊断中的作用。

IF 2.7

Expert review of respiratory medicine Pub Date : 2026-03-01 Epub Date: 2025-08-14 DOI: 10.1080/17476348.2025.2541427

Gino Soldati, Andrea Smargiassi, Alessandro Perrotta, Giovanni Pierro, Roberto Barone, Lorenzo Carriera, Gabriele Labinac, Riccardo Inchingolo

{"title":"An update on the role of ultrasound lung artifacts in the diagnosis of respiratory diseases.","authors":"Gino Soldati, Andrea Smargiassi, Alessandro Perrotta, Giovanni Pierro, Roberto Barone, Lorenzo Carriera, Gabriele Labinac, Riccardo Inchingolo","doi":"10.1080/17476348.2025.2541427","DOIUrl":"10.1080/17476348.2025.2541427","url":null,"abstract":"Introduction: Lung ultrasound has consolidated over the years its valuable role in supporting routine clinical activity in different settings. Every disease that alters peripheral airspace geometry can generate a superficial structure with low impedance mismatch which can be capable of trapping ultrasound waves within reflective interfaces.Areas covered: Qualitative approaches to the description of horizontal and vertical acoustic artifacts have been adopted by physicians for a long time with the consequence of poor diagnostic accuracy and reproducibility. Semi-quantitative methods try to fill the gaps in the operator's qualitative assessments. Finally, quantitative approaches aim to overcome the interpretative biases of visual evaluations of the ultrasound image through measures related to the characteristics of the acoustic traps at the level of the pleural line.Expert opinion: Current research on the genesis of vertical artifacts and their contribution to the characterization of respiratory diseases is benefiting from the synergies among physicians, engineers, and physicists. The 'acoustic trap' hypothesis, with its effects on the generation of vertical artifacts resulting from the morphology of the trap itself and transmission imaging parameters, represents one of the fronts of ongoing scientific research on innovative methods for the quantitative characterization of lung parenchyma.","PeriodicalId":94007,"journal":{"name":"Expert review of respiratory medicine","volume":" ","pages":"241-250"},"PeriodicalIF":2.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0